Ionis Pharmaceuticals Inc (IONS)

Nov 21, 2025

Can Ionis Pharmaceuticals Inc. (ISI) stock sustain revenue momentumFed Meeting & Daily Oversold Bounce Ideas - newser.com

Nov 21, 2025

Nov 21, 2025

Is Ionis Pharmaceuticals Inc. stock a defensive play in 2025Weekly Trading Summary & Weekly Return Optimization Plans - newser.com

Nov 21, 2025

Nov 20, 2025

Insider Sell: Joan Herman Sells 44,000 Shares of Ionis Pharmaceuticals Inc (IONS) - GuruFocus

Nov 20, 2025

Nov 20, 2025

Can Ionis Pharmaceuticals Inc. (ISI) stock stage a strong rebound this quarterWeekly Volume Report & Weekly Breakout Opportunity Watchlist - newser.com

Nov 20, 2025

Nov 20, 2025

Is Ionis Pharmaceuticals Inc. (ISI) stock undervalued after correctionWatch List & Fast Entry Momentum Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

Will Ionis Pharmaceuticals Inc. stock pay special dividendsJuly 2025 Sector Moves & Safe Swing Trade Setups - newser.com

Nov 20, 2025

Nov 19, 2025

Arrowhead’s Redemplo Approval Sets Up Standoff With Ionis’s Tryngolza - Citeline News & Insights

Nov 19, 2025

Nov 19, 2025

How Ionis Pharmaceuticals Inc. stock trades during market volatilityQuarterly Profit Report & AI Driven Price Forecasts - newser.com

Nov 19, 2025

Nov 19, 2025

Why Ionis Pharmaceuticals Inc. stock attracts high net worth investorsWeekly Profit Analysis & Real-Time Chart Pattern Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Arrowhead Pharmaceuticals Steps Into The Rare Disease Market - Finimize

Nov 19, 2025

Nov 19, 2025

Price momentum metrics for Ionis Pharmaceuticals Inc. explained2025 Market Outlook & Intraday High Probability Setup Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is Ionis Pharmaceuticals Inc. (ISI) stock attractive post correctionPortfolio Gains Report & Consistent Profit Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

How Ionis Pharmaceuticals Inc. (ISI) stock compares with tech leaders2025 Momentum Check & Stock Portfolio Risk Management - newser.com

Nov 19, 2025

Nov 18, 2025

With FDA Approval for RNAi Drug, Arrowhead Pharma Starts Price War With Rival Ionis - MedCity News

Nov 18, 2025

Nov 18, 2025

US FDA approves Arrowhead's genetic disorder drug - Reuters

Nov 18, 2025

Nov 18, 2025

Arrowhead’s plozasiran cleared for FCS; Ionis patent duel awaits - BioWorld MedTech

Nov 18, 2025

Nov 18, 2025

RNAi biotech Arrowhead wins first FDA approval - BioPharma Dive

Nov 18, 2025

Nov 17, 2025

Ionis Pharmaceuticals Completes $770M Convertible Notes Offering - TipRanks

Nov 17, 2025

Nov 17, 2025

Ionis Pharmaceuticals (IONS) Price Target Increased by 10.27% to 85.25 - Nasdaq

Nov 17, 2025

Nov 17, 2025

Arrowhead Pharmaceuticals: Important Catalysts And Some Challenges Ahead (NASDAQ:ARWR) - Seeking Alpha

Nov 17, 2025

Nov 17, 2025

DAWNZERA™ (donidalorsen) receives positive opinion from CHMP, recommended for approval in EU for hereditary angioedema (HAE) - BioSpace

Nov 17, 2025

Nov 15, 2025

Can Ionis Pharmaceuticals Inc. stock sustain free cash flow growthTrade Signal Summary & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 15, 2025

Nov 15, 2025

What Recent Clinical Trial Updates Mean for Ionis Pharmaceuticals Stock Valuation in 2025 - Yahoo Finance

Nov 15, 2025

Nov 14, 2025

Will Ionis Pharmaceuticals Inc. stock deliver better than expected guidanceTrade Signal Summary & Expert Approved Momentum Ideas - newser.com

Nov 14, 2025

Nov 14, 2025

Biogen Completes Acquisition of Alcyone Therapeutics - Benzinga

Nov 14, 2025

Nov 14, 2025

Ionis Pharmaceuticals stock rises after positive EU regulatory opinion By Investing.com - Investing.com India

Nov 14, 2025

Nov 14, 2025

Ionis Pharmaceuticals stock rises after positive EU regulatory opinion - Investing.com

Nov 14, 2025

Nov 14, 2025

Sanofi, Lilly among winners of EU drug recommendations this week - Seeking Alpha

Nov 14, 2025

Nov 14, 2025

Ionis Pharmaceuticals (IONS) Advances with European Review for D - GuruFocus

Nov 14, 2025

Nov 14, 2025

Is Ionis Pharmaceuticals Inc. stock in correction or buying zone2025 Market WrapUp & Intraday High Probability Alerts - Fundação Cultural do Pará

Nov 14, 2025

Nov 14, 2025

Ionis Pharmaceuticals Says Dawnzera Recommended for Approval in EU for Hereditary Angioedema - MarketScreener

Nov 14, 2025

Nov 14, 2025

EU committee recommends approval of Ionis’ HAE treatment By Investing.com - Investing.com Canada

Nov 14, 2025

Nov 14, 2025

DAWNZERA Receives Positive Opinion From CHMP, Recommended For Approval In EU For Hereditary Angioedema - TradingView

Nov 14, 2025